NCT00944905 Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) Status COMPLETED Phase PHASE1
NCT00934440 A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT00923845 Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer Status COMPLETED Phase PHASE2
NCT00923520 A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00923169 Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma) Status COMPLETED Phase PHASE1
NCT00923130 Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer Status COMPLETED Phase PHASE2
NCT00918775 Follow-up After Metastasectomy in Patients With Kidney Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00918281 Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection Status COMPLETED Phase PHASE2
NCT00903175 Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00884520 An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037 Status COMPLETED Phase EARLY_PHASE1
NCT00876382 Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma Status COMPLETED Phase N/A
NCT00869011 Exercise for Patients With Renal Cell Cancer Receiving Sunitinib Status UNKNOWN Phase PHASE3
NCT00862303 DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma Status UNKNOWN Phase PHASE1/PHASE2
NCT00836745 Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent Status COMPLETED Phase N/A
NCT00827359 Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00788060 A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma Status COMPLETED Phase PHASE1